Cybin Inc. Acquires Small Pharma Inc.
August 28, 2023
Cybin Inc. has agreed to acquire all issued and outstanding securities of U.K.-based Small Pharma in an all‑share plan of arrangement. The transaction combines Cybin's and Small Pharma's clinical-stage psychedelic therapeutic programs and IP into a single, publicly traded clinical‑stage biopharmaceutical company headquartered in Toronto.
- Buyers
- Cybin Inc.
- Targets
- Small Pharma Inc.
- Industry
- Biotechnology
- Location
- England, United Kingdom
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.